Alder Biopharmaceuticals Growth, Revenue, Number of Employees and Funding

Overview

Location:
Seattle, WA USA
Total Funding:$525M
Industry:Biotech
Founded:2004
Lead Investor(s):N/A
Press

City Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Alder Biopharmaceuticals's estimated revenue is currently $41.1M per year.
  • Alder Biopharmaceuticals received $287.5M in venture funding in February 2018.
  • Alder Biopharmaceuticals's estimated revenue per employee is $144630
  • Alder Biopharmaceuticals's total funding is $525M.

Employee Data

  • Alder Biopharmaceuticals has 284 Employees.
  • Alder Biopharmaceuticals grew their employee count by 19% last year.
  • Alder Biopharmaceuticals currently has 5 job openings.

Executive Contacts

NameTitle
Randall SchatzmanPresident and CEO
John LathamChief Scientific Officer
Jeffrey SmithManaging Director
Elisabeth SandovalChief Commercial Officer and EVP Corporate Strategy
Angela WillisVice President, Market Access
Shannon CarstensAssociate Director, QA Compliance
Larry BenedictExecutive Vice President and Principal Accounting Officer
Hassan MadaniDirector, CMC Commercialization
Dario GobunquinAssoc. Director of Finance
Kate CernokDirector, Medical Communications

What Is Alder Biopharmaceuticals?

Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder plays two roles: As a biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. The work being done at Alder today will help those who suffer from cancer, autoimmune diseases, and inflammatory diseases. As a licensing partner, Alder is revolutionizing the way the pharmaceutical industry discovers, develops and produces antibody therapeutics. Through various licensing agreements, Alder has used its proprietary technology to help major biopharmaceutical partners advance novel therapeutics to the clinic in less time and at lower cost. Alder's licensing strategy also includes identifying strategic partners to assist in the development and marketing of its preclinical and clinical pipeline programs.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

284

Number of Employees

$41.1M

Revenue (est)

5

Current Jobs

19%

Employee Growth %

$525M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Phytelligence
$12.7M88-15%$20M
RareCyte
$8.7M6015%$35M
Alpine Immune S...
$6.8M5619%$52.6M
NanoString Tech...
$85.1M58714%
VMRD
$5.4M376%
Global Medical ...
$6.2M4310%
Inventprise
$6.2M438%
Allen Institute...
$24.2M1675%
Silverback Ther...
$5.6M3918%
Arzeda
$5.1M3535%

Alder Biopharmaceuticals News

09/03/2019 - Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache Society

Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache Society.

09/08/2019 - Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOTHELL, Wash., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (ALDR), a biopharmaceutical company focused on ...

09/03/2019 - Alder BioPharmaceuticals® to Present at Two Upcoming September Investor Conferences

BOTHELL, Wash., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (ALDR), a biopharmaceutical company focused on ...

Alder Biopharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2005-08-16$11.1MAMultipleArticle
2006-07-10$16.0MBH.I.G. VenturesArticle
2008-01-14$40.0MCTPG Biotech, Delphi VenturesArticle
2012-04-20$38.0MDNovo VenturesArticle
2012-08-28$3.5MUndisclosedBristol-Myers SquibbArticle
2015-01-09$177.0MUndisclosedCredit SuisseArticle
2015-06-26$230.0MUndisclosedCredit SuisseArticle
2017-07-14$172.5MUndisclosedLeerink Partners LLCArticle
2018-01-09$100.0MUndisclosedRedmile Group LLCArticle
2018-01-30$230.0MUndisclosedGoldman Sachs & Co. LLC,Article
2018-02-05$287.5MUndisclosedGoldman Sachs & Co. LLC,Article

Alder Biopharmaceuticals Executive Hires

DateNameTitleReference
2009-08-13Mark YoungSVP Pharmaceutical OperationsArticle
2016-06-07Roger K. CadyVP neurologyArticle
2016-06-30Timothy M. WhitakerChief Medical OfficerArticle
2016-09-07Elisabeth A. SandovalChief Commercial OfficerArticle
2016-09-22Nancy L. BomanSVP Regulatory Affairs/PharmacovigilanceArticle
2016-10-12Larry BenedictEVP/Principal Accounting OfficerArticle
2018-03-21Paul ClevelandInterim President & CEOArticle
2018-04-17Erin LavelleChief Operating OfficerArticle
2018-04-24Eric CarterInterim Chief Medical OfficerArticle
2019-01-18Paul Streckchief medical officerArticle